# OnCo record paper-cd19-dlbcl-am-j-hematol-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-cd19-dlbcl-am-j-hematol-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-cd19-dlbcl-am-j-hematol-2021" ;
  schema:name "Efficacy and safety of CD19-directed CAR-T cell therapies in patients with relapsed/refractory aggressive B-cell lymphomas: Observations from the JULIET, ZUMA-1, and TRANSCEND trials"@en ;
  schema:description "Review on CD19 in Diffuse large B-cell lymphoma, in American journal of hematology (2021), one of the most cited Europe PMC records with CD19 in its title."@en ;
  schema:url <https://onco.cc/key-papers/paper-cd19-dlbcl-am-j-hematol-2021/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1002/ajh.26301>, <https://pubmed.ncbi.nlm.nih.gov/34310745/>, <https://europepmc.org/article/MED/34310745> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1002/ajh.26301> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Westin JR, Kersten MJ, Salles G, et al." .